A detailed history of Brown Advisory Inc transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Brown Advisory Inc holds 2,298 shares of BIO stock, worth $776,103. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,298
Previous 3,520 34.72%
Holding current value
$776,103
Previous $961,000 20.08%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$263.97 - $344.64 $322,571 - $421,150
-1,222 Reduced 34.72%
2,298 $768,000
Q2 2024

Aug 14, 2024

SELL
$268.26 - $339.48 $3.47 Million - $4.39 Million
-12,922 Reduced 78.59%
3,520 $961,000
Q1 2024

Apr 24, 2024

BUY
$304.11 - $351.99 $265,488 - $307,287
873 Added 5.61%
16,442 $5.69 Million
Q4 2023

Feb 08, 2024

SELL
$269.37 - $365.04 $253 Million - $343 Million
-940,163 Reduced 98.37%
15,569 $5.03 Million
Q3 2023

Oct 24, 2023

BUY
$350.25 - $422.63 $10.1 Million - $12.1 Million
28,724 Added 3.1%
955,732 $343 Million
Q2 2023

Jul 31, 2023

BUY
$359.49 - $486.4 $29 Million - $39.2 Million
80,607 Added 9.52%
927,008 $351 Million
Q1 2023

May 08, 2023

BUY
$418.69 - $503.0 $10.7 Million - $12.8 Million
25,516 Added 3.11%
846,401 $405 Million
Q4 2022

Feb 13, 2023

BUY
$351.71 - $456.01 $15.9 Million - $20.6 Million
45,173 Added 5.82%
820,885 $345 Million
Q3 2022

Nov 14, 2022

BUY
$412.59 - $563.26 $80 Million - $109 Million
193,896 Added 33.33%
775,712 $324 Million
Q2 2022

Nov 14, 2022

BUY
$463.67 - $597.16 $37,093 - $47,772
80 Added 0.01%
581,816 $288 Million
Q2 2022

Sep 13, 2022

SELL
$463.67 - $597.16 $21.9 Million - $28.2 Million
-47,144 Reduced 7.49%
582,701 $288 Million
Q2 2022

Aug 02, 2022

BUY
$463.67 - $597.16 $40.6 Million - $52.3 Million
87,596 Added 16.15%
629,845 $314 Million
Q1 2022

Nov 14, 2022

SELL
$524.57 - $735.42 $506,210 - $709,680
-965 Reduced 0.17%
581,736 $328 Million
Q1 2022

Sep 13, 2022

SELL
$524.57 - $735.42 $20.8 Million - $29.2 Million
-39,675 Reduced 6.82%
542,249 $305 Million
Q1 2022

May 09, 2022

BUY
$524.57 - $735.42 $22.3 Million - $31.3 Million
42,563 Added 7.89%
581,924 $330 Million
Q4 2021

Jan 27, 2022

SELL
$708.84 - $794.68 $22.6 Million - $25.3 Million
-31,847 Reduced 5.58%
539,361 $408 Million
Q3 2021

Nov 12, 2021

BUY
$657.71 - $825.77 $1.3 Million - $1.63 Million
1,976 Added 0.35%
571,208 $426 Million
Q2 2021

Jul 29, 2021

BUY
$576.64 - $649.04 $21.4 Million - $24 Million
37,045 Added 6.96%
569,232 $367 Million
Q1 2021

May 14, 2021

BUY
$547.01 - $662.35 $30.9 Million - $37.4 Million
56,515 Added 11.88%
532,187 $304 Million
Q4 2020

Feb 12, 2021

BUY
$510.68 - $643.45 $5.24 Million - $6.6 Million
10,263 Added 2.21%
475,672 $277 Million
Q3 2020

Nov 16, 2020

BUY
$454.43 - $535.6 $22.8 Million - $26.9 Million
50,277 Added 12.11%
465,409 $240 Million
Q2 2020

Aug 14, 2020

BUY
$334.87 - $493.06 $23.7 Million - $34.9 Million
70,846 Added 20.58%
415,132 $187 Million
Q1 2020

May 15, 2020

BUY
$320.01 - $409.07 $37 Million - $47.4 Million
115,774 Added 50.66%
344,286 $121 Million
Q4 2019

Feb 14, 2020

BUY
$319.73 - $374.2 $73.1 Million - $85.5 Million
228,512 New
228,512 $84.6 Million
Q2 2019

Aug 12, 2019

SELL
$286.93 - $312.59 $351,776 - $383,235
-1,226 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$224.3 - $317.41 $35,663 - $50,468
159 Added 14.9%
1,226 $376,000
Q4 2018

Feb 13, 2019

BUY
$220.1 - $309.0 $30,593 - $42,951
139 Added 14.98%
1,067 $248,000
Q3 2018

Nov 13, 2018

BUY
$289.28 - $326.15 $5,207 - $5,870
18 Added 1.98%
928 $291,000
Q2 2018

Aug 10, 2018

SELL
$244.1 - $303.88 $9,764 - $12,155
-40 Reduced 4.21%
910 $262,000
Q1 2018

Jun 28, 2018

BUY
$233.97 - $274.11 $222,271 - $260,404
950 New
950 $238,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.32B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Brown Advisory Inc Portfolio

Follow Brown Advisory Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Advisory Inc, based on Form 13F filings with the SEC.

News

Stay updated on Brown Advisory Inc with notifications on news.